CorMedix Inc
Suletud
SektorTervishoid
8.72 -2.13
Ülevaade
Aktsiahinna muutus
24h
Min
8.71
Max
8.81
Sissetulek | 25M 39M |
|---|---|
Müük | -1.2M 127M |
P/E Sektori keskmine | 3.936 49.052 |
Aktsiakasum | 0.35 |
Kasumimarginaal | 30.293 |
Töötajad | 191 |
EBITDA | 7.7M 74M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +63.04% upside |
Järgmine tulemuste avaldamine | 6. aug 2026 |
|---|
Turukapital | 69M 670M |
|---|---|
Eelmine avamishind | 10.85 |
Eelmine sulgemishind | 8.72 |
Uudiste sentiment
By Acuity
67%
33%
302 / 342 Pingereas Healthcare
CorMedix Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
